NASDAQ$AHCO
AdaptHealth Corp. · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Announced financial results for the second quarter ended June 30, 2021.
AdaptHealth Corp. announced strong financial results for the second quarter, driven by the full quarter impact of AeroCare and realization of integration synergies. The company is experiencing organic growth and making strategic acquisitions. They are also increasing financial guidance for fiscal year 2021.
- Financial results were driven by a full quarter of AeroCare and realization of integration synergies.
- The business continues to grow organically as well as through strategic acquisitions in key markets.
- The company acquired several businesses including Spiro Health Services and Healthy Living Medical Supplies.
- The e-prescribe technology in diabetes has improved patient and provider satisfaction through reduced cycle time.
Headline financials
Revenue & EPS history
AdaptHealth · Revenue · Quarterly
$617M
Forward guidance
Based on current business and market trends, the Company is increasing its previously issued financial guidance for fiscal year 2021.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
+0.6%
Avg return
Earnings day
+1.4%
Avg return
5 days after
+1.6%
Avg return
30 days after
52%
16 / 31 earnings
Positive
+34.6%
Q4 2023
Best reaction
-27.9%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -10.0% | -13.4% | -25.6% | |
| Q4 2025 | -14.2% | -11.1% | +10.9% | |
| Q3 2025 | +17.2% | +4.5% | +3.2% | |
| Q1 2025 | +1.7% | -1.4% | +3.7% | |
| Q4 2024 | +24.4% | +33.1% | +24.4% | |
| Q3 2024 | +0.3% | -0.6% | -4.2% | |
| Q2 2024 | -17.2% | -14.1% | +4.6% | |
| Q1 2024 | -8.6% | -8.8% | +4.9% | |
| Q4 2023 | +34.6% | +37.9% | +50.9% | |
| Q3 2023 | -23.1% | -18.6% | -5.6% | |
| Q2 2023 | +11.1% | +4.4% | -19.8% | |
| Q1 2023 | -8.4% | -12.2% | -13.8% | |
| Q4 2022 | -27.9% | -27.9% | -40.6% | |
| Q3 2022 | -1.6% | +8.4% | +4.5% | |
| Q2 2022 | -8.9% | -8.2% | -25.7% | |
| Q1 2022 | +23.7% | +42.2% | +53.6% | |
| Q4 2021 | +4.1% | +2.3% | +2.8% | |
| Q3 2021 | -5.4% | -7.2% | -24.1% | |
| Q2 2021 | +16.4% | +13.4% | +12.3% | |
| Q1 2021 | -8.5% | -14.9% | -10.4% | |
| Q4 2020 | +2.1% | +12.4% | +21.7% | |
| Q3 2020 | +2.6% | +0.6% | +19.5% | |
| Q2 2020 | +13.9% | +18.0% | +7.0% | |
| Q1 2020 | +1.6% | +5.8% | +5.5% | |
| Q4 2019 | +1.8% | +1.4% | -7.7% | |
| Q3 2019 | -4.1% | -4.9% | -3.3% | |
| Q2 2019 | +0.0% | +0.0% | -0.6% | |
| Q1 2019 | +0.0% | +0.0% | +0.3% | |
| Q4 2018 | +0.6% | +0.7% | +1.3% | |
| Q3 2018 | +0.3% | +0.1% | +0.4% | |
| Q2 2018 | +0.0% | +0.3% | +0.1% | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro